Variabilidad en la determinación del estado de HER2 por inmunohistoquímica en Chile

This study confirms that, in order to make the correct therapeutic decision, the IHC technique used in the assessment of HER2 status should undergo stringent internal and external quality controls. Technical and interpretative procedures should be standardized according to international recommendations.